Statins linked to dementia risk reduction and elderly survival outcomes

Recent medical studies published in The Lancet journals have provided new insights into the use of statins for older adults and their potential secondary benefits.

A French trial involving 1,180 participants examined whether continuing cholesterol-lowering statins in adults aged 75 and older—who have no history of heart disease or stroke—impacts survival. The study found that stopping statins did not meaningfully worsen survival rates over a three-year period compared to continuing treatment. Specifically, 7.2% of the group that stopped treatment died, compared to 7.9% in the group that continued.

Separately, research involving over 130,000 participants with type 2 diabetes suggests that statin use may be linked to a reduced risk of dementia. The study found that individuals prescribed an early statin intervention were 15% less likely to develop dementia than those who took no statins. Experts suggest these findings highlight the vascular components of brain health and the potential for preventive solutions through cholesterol management.